Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Debt Conversion, Converted Instrument, Amount

2.8 / 5 stars · 68/120 Roast Me

ACCURAY INCORPORATED Debt Conversion, Converted Instrument, Amount

ACCURAY INCORPORATED (ARAY) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-09-07

  • ACCURAY INCORPORATED debt conversion, converted instrument, amount for fiscal 2023 was $0.00.
  • ACCURAY INCORPORATED debt conversion, converted instrument, amount for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • ACCURAY INCORPORATED debt conversion, converted instrument, amount for fiscal 2021 was $97.15M.
  • ACCURAY INCORPORATED debt conversion, converted instrument, amount for fiscal 2020 was $0.00.
Period endDebt Conversion, Converted Instrument, Amount 12 month
2023-06-30$0.00
10-K · filed 2023-09-07
2022-06-30$0.00
10-K · filed 2023-09-07
2021-06-30$97.15M
10-K · filed 2023-09-07
2020-06-30$0.00
10-K · filed 2022-08-17
2018-06-30$6.64M
10-K · filed 2020-08-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10